MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-10-0016238
Bayle's Pharmaceutical Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹47.5 Lakh
▲ 10% YoY
Net profit · FY 2025
₹2.19 Lakh
Net margin 4.6%
EBITDA · FY 2025
₹3.28 Lakh
EBITDA margin 6.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Bayle's Pharmaceutical Private Limited
Data last updated:
Bayle's Pharmaceutical Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299DL2018PTC340995. Its GSTIN is 20AAICB0857H1Z0 (Jharkhand).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rekha Devi and Mukesh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kh No 134/9 G.Floor A – Block Jai Vihar Ram Nagar Najafgarh New Delhi, Delhi, India – 110043.
As per the financials filed for FY 2025, the company reported a revenue of ₹47.5 Lakh, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹2.19 Lakh (net margin 4.6%) and EBITDA of ₹3.28 Lakh (EBITDA margin 6.9%). Revenue has grown at a compounded annual rate (CAGR) of 65% over three years.
Bayle's Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-10-0016238). For more details, the company can be reached via its website baylespharma.com.
Company details
CIN U24299DL2018PTC340995
Registration Number 340995
Incorporation Date 24 October 2018
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-10-0016238
Key People
Rekha Devi Director Mukesh Kumar Director Recognitions & Rankings of Bayle's Pharmaceutical
Contact details
Bayle's Pharmaceutical Private Limited's registered office is in New Delhi, Delhi. Its website is baylespharma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressKh No 134/9 G.Floor A – Block Jai Vihar Ram Nagar Najafgarh New Delhi, Delhi, India – 110043
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Bayle's Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Bayle's Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Bayle's Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Bayle's Pharmaceutical Private Limited, buy the company report.
Financials of Bayle's Pharmaceutical Private Limited
FY 2025 filings availableBayle's Pharmaceutical Private Limited reported revenue of ₹47.5 Lakh (up 10% YoY) for FY 2025.
Revenue · FY 2025
₹47.5 Lakh ▲ 10%
Net profit · FY 2025
₹2.19 Lakh margin 4.6%
EBITDA · FY 2025
₹3.28 Lakh margin 6.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 65%
EBITDA CAGR growth
1 year
▲ 234%
3 years · compounded
▲ 202%
5 years · compounded
▲ 76%
Revenue has grown at a compounded annual rate (CAGR) of 65% over three years, including 10% growth in the latest year. EBITDA rose 234% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.28 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.19 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.9% | ||||
| Net Profit Margin | 4.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bayle's Pharmaceutical Private Limited, buy the company report.
Board of directors of Bayle's Pharmaceutical Private Limited
Bayle's Pharmaceutical has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rekha Devi | Director | 24 Oct 2018 | 8 Years 0 Months | Current |
| Mukesh Kumar | Director | 28 Sep 2024 | 2 Years 1 Months | Current |
Peer comparison
Bayle's Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Maxcare Drugs Private Limited | ₹47.57 Lakh (FY 2025) | 36.0% | Mumbai, Maharashtra, India | |||
| Vinson Animal Care Private Limited | ₹47.57 Lakh (FY 2025) | 19.0% | Kolkata, West Bengal, India | |||
| Kapeeshwar Chemicals Private Limited | ₹47.55 Lakh (FY 2025) | -93.0% | Delhi, India | |||
| Opg Biotech Private Limited | ₹47.52 Lakh (FY 2025) | -32.0% | New Delhi, Delhi, India | |||
| Swadeshi Aushdhi Private Limited | ₹47.52 Lakh (FY 2018) | 98.0% | New Delhi, Delhi, India | |||
| Bayle's Pharmaceutical Private Limitedthis company | ₹47.5 Lakh (FY 2025) | ₹2.19 Lakh | 4.6% | 10.0% | New Delhi, Delhi, India | |
| Sun Agrozinc Private Limited | ₹47.48 Lakh (FY 2022) | -75.0% | Delhi, India | |||
| Tricorus Healthcare Private Limited | ₹47.47 Lakh (FY 2024) | -73.0% | Bangalore, Karnataka, India | |||
| PDDR Medical Products & Services (I) Private Limited | ₹47.46 Lakh (FY 2019) | 32.0% | Nagpur, Maharashtra, India | |||
| Triumph Pharmaceuticals Private Limited | ₹47.46 Lakh (FY 2025) | 5.0% | Mysore, Karnataka, India | |||
| G.N.Organics Private Limited | ₹47.41 Lakh (FY 2024) | Kota, Rajasthan, India |
To see the full peer comparison of Bayle's Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bayle's Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bayle's Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bayle's Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 20AAICB0857H1Z0 | Jharkhand | Active | 19 Jan 2019 |
To see the full GST registrations and return filing status of Bayle's Pharmaceutical Private Limited, buy the company report.
Recent activity
Bayle's Pharmaceutical Private Limited has 5 board changes on record since 2018: 2 appointments and 3 cessations. The latest: Mukesh Kumar was appointed as Director on 28 Sep 2024.
AGM
Bayle'S Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Bayle'S Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Appointed
Mukesh Kumar was appointed as Director.
Ceased
Priya Kumari ceased to be Director.
Ceased
Niharika ceased to be Additional Director.
Ceased
Sushila Devi ceased to be Director.
Appointed
Rekha Devi was appointed as Director.
Incorporation
24 Oct 2018
Bayle'S Pharmaceutical Private Limited was registered on 24 Oct 2018 with Roc Delhi I & aged 8 years 8 days as per MCA records.
Frequently asked questions
Bayle's Pharmaceutical is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 October 2018 (8+ years old) and is registered under CIN U24299DL2018PTC340995.
Bayle's Pharmaceutical has 2 current directors:
- Rekha Devi - Director
- Mukesh Kumar - Director
The latest financial statements of Bayle's Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Bayle's Pharmaceutical is 20AAICB0857H1Z0, registered in Jharkhand.
The CIN (Corporate Identification Number) of Bayle's Pharmaceutical is U24299DL2018PTC340995. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bayle's Pharmaceutical was incorporated on 24 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Bayle's Pharmaceutical by revenue are Maxcare Drugs Private Limited, Vinson Animal Care Private Limited, Kapeeshwar Chemicals Private Limited, Opg Biotech Private Limited, Swadeshi Aushdhi Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mukesh Kumar was appointed as Director on 28 Sep 2024. Priya Kumari ceased to be Director on 28 Sep 2024. Niharika ceased to be Additional Director on 16 Sep 2021. Bayle's Pharmaceutical has 5 board changes on record in total.
Yes, Bayle's Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-10-0016238).
Bayle's Pharmaceutical can be reached through the website baylespharma.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Bayle's Pharmaceutical is at Kh No 1349 G.Floor A – Block Jai Vihar Ram Nagar Najafgarh New Delhi, Delhi, India – 110043.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages